September 30, 2025

Early Treatment Key in Sudden Deafness?

Treatment within 7 days improved hearing in sudden deafness, while adjunct therapies offered limited benefit.

Conexiant

September 30, 2025

COVID Tied to Hidden Smell Deficits

COVID-19 may leave behind unrecognized olfactory deficits linked to cognitive complaints.

Conexiant

September 29, 2025

Adult OSA Outcomes With Maxillary Expansion

Airway volume enlarges and oxygen levels rise with maxillary expansion in OSA patients.

Conexiant

September 26, 2025

Old Medicine, New Hope for Speech?

Leucovorin, a folic acid–derived drug, is under study for speech benefits in children with autism.

KFF Health News

September 26, 2025

FDA Approves First Once-Daily Oral Therapy for Acromegaly

Once-daily paltusotine offers an oral alternative to monthly injections for eligible adults.

Conexiant

September 17, 2025

Combatting Deafness with Gene Therapy

Researchers restore hearing and balance in mice by replacing defective protein; work highlights gene therapy’s potential for certain forms of inherited deafness.

The Medicine Maker

September 15, 2025

Chronic Insomnia Accelerates Cognitive Decline

Mayo Clinic study links chronic insomnia to 40% higher risk of cognitive impairment in older adults

Conexiant

September 12, 2025

Hearing Loss May Lower Employment and Income Odds

National cohort data showed hearing loss tied to reduced work participation and pay with certain demographics impacted more than others.

Conexiant

September 12, 2025

Cemiplimab Reduces Recurrence in High-Risk cSCC

First adjuvant immunotherapy trial shows 23% absolute reduction in recurrence for resected cutaneous squamous cell carcinoma.

Conexiant